This Article Full Text Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by McKay, M. K. Articles by Hester, R. L. Search for Related Content PubMed PubMed Citation Articles by McKay, M. K. Articles by Hester, R. L. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Hazardous Substances DB NITRIC OXIDE

(Hypertension. 1996;28:202-208.)
© 1996 American Heart Association, Inc.

Articles

Role of Nitric Oxide, Adenosine, and ATP-Sensitive Potassium Channels in Insulin-Induced Vasodilation

Mary K. McKay; Robert L. Hester

the Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson.

The resistance of various tissues to the vasodilator and metabolic effects of insulin may be an important risk factor in the genesis of hypertension observed in several pathological states. Because of this, it is important to understand the mechanisms by which insulin causes vasodilation. Because insulin is known to raise metabolism, one mechanism by which insulin causes vasodilation could be through metabolic vasodilation. Recently, however, it has been suggested that the insulin-induced vasodilation is mediated by the release of endothelium-derived nitric oxide. Using a model of muscle microcirculation (hamster cremaster), we examined the interactions between insulin, nitric oxide, and tissue metabolism to understand the potential mechanisms by which insulin causes vasodilation. Topical application of insulin (200 µU/mL) to the cremaster resulted in significant increases in arteriolar diameter. Second-order arteriolar diameter increased from 69.6±6 to 79.8±5 µm and fourth-order arteriolar diameter from 11.3±1 to 15.1±2 µm (n=8). During nitric oxide synthase inhibition, topical application of insulin caused significant vasodilation in both second- and fourth-order arterioles. In contrast, both adenosine receptor antagonism and blockade of ATP-sensitive potassium channels prevented insulin-induced increases in arteriolar diameter. Our findings suggest a role for increased tissue metabolism, particularly the metabolite adenosine, in mediating insulin-induced vasodilation.

Key Words: arterioles • insulin • microcirculation • vasodilation

This article has been cited by other articles:

				I. Fleming Double Tribble: Two TRIB3 Variants, Insulin, Akt, and eNOS Arterioscler. Thromb. Vasc. Biol., July 1, 2008; 28(7): 1216 - 1218. [Full Text] [PDF]

				R. J. Widmer, R. H. Stewart, M. F. Young, J. E. Laurinec, G. A. Laine, and C. M. Quick Application of local heat induces capillary recruitment in the Pallid bat wing Am J Physiol Regulatory Integrative Comp Physiol, June 1, 2007; 292(6): R2312 - R2317. [Abstract] [Full Text] [PDF]

				V. Randriamboavonjy, J. Schrader, R. Busse, and I. Fleming Insulin Induces the Release of Vasodilator Compounds From Platelets by a Nitric Oxide-G Kinase-VAMP-3-dependent Pathway J. Exp. Med., February 2, 2004; 199(3): 347 - 356. [Abstract] [Full Text] [PDF]

				M. G. Clark, M. G. Wallis, E. J. Barrett, M. A. Vincent, S. M. Richards, L. H. Clerk, and S. Rattigan Blood flow and muscle metabolism: a focus on insulin action Am J Physiol Endocrinol Metab, February 1, 2003; 284(2): E241 - E258. [Abstract] [Full Text] [PDF]

				H. M. O. Farouque and I. T. Meredith Inhibition of vascular ATP-sensitive K+ channels does not affect reactive hyperemia in human forearm Am J Physiol Heart Circ Physiol, February 1, 2003; 284(2): H711 - H718. [Abstract] [Full Text] [PDF]

				C. L. Oltman, N. L. Kane, D. D. Gutterman, R. S. Bar, and K. C. Dellsperger Mechanism of coronary vasodilation to insulin and insulin-like growth factor I is dependent on vessel size Am J Physiol Endocrinol Metab, July 1, 2000; 279(1): E176 - E181. [Abstract] [Full Text] [PDF]

				P. Arvola, X. Wu, M. Kahonen, H. Makynen, A. Riutta, I. Mucha, T. Solakivi, H. Kainulainen, and I. Porsti Exercise enhances vasorelaxation in experimental obesity associated hypertension Cardiovasc Res, September 1, 1999; 43(4): 992 - 1002. [Abstract] [Full Text] [PDF]

				C. A. Schroeder Jr., Y.-L. Chen, and E. J. Messina Inhibition of NO synthesis or endothelium removal reveals a vasoconstrictor effect of insulin on isolated arterioles Am J Physiol Heart Circ Physiol, March 1, 1999; 276(3): H815 - H820. [Abstract] [Full Text] [PDF]

				P. T Bryan and J. M Marshall Cellular mechanisms by which adenosine induces vasodilatation in rat skeletal muscle: significance for systemic hypoxia J. Physiol., January 1, 1999; 514(1): 163 - 175. [Abstract] [Full Text] [PDF]

				D. Hasdai, D. R. Holmes Jr., D. M. Richardson, U. Izhar, and A. Lerman Insulin and IGF-I attenuate the coronary vasoconstrictor effects of endothelin-1 but not of sarafotoxin 6c Cardiovasc Res, September 1, 1998; 39(3): 644 - 650. [Abstract] [Full Text] [PDF]

				D. Hasdai, R. A. Rizza, D. R. Holmes Jr, D. M. Richardson, P. Cohen, and A. Lerman Insulin and Insulin-like Growth Factor-I Cause Coronary Vasorelaxation In Vitro Hypertension, August 1, 1998; 32(2): 228 - 234. [Abstract] [Full Text] [PDF]

				G. M. Pieper Review of Alterations in Endothelial Nitric Oxide Production in Diabetes : Protective Role of Arginine on Endothelial Dysfunction Hypertension, May 1, 1998; 31(5): 1047 - 1060. [Full Text] [PDF]